Buchalter PC has significantly bolstered its capabilities in the medical technology sector by appointing a seasoned intellectual property attorney from Procopio Cory Hargreaves & Savitch LLP to lead its medical technology practice group. This strategic move, announced on Wednesday, aims to leverage the attorney’s extensive expertise in intellectual property law to drive growth and innovation within the firm’s burgeoning medical tech division. Read more.
The newly appointed chair’s experience at Procopio Cory Hargreaves & Savitch LLP included managing complex IP portfolios and advising leading biotech companies, which positions them well to address the evolving demands of Buchalter’s clients. This comes at a pivotal time as the healthcare and medical technology sectors continue to expand rapidly, necessitating sophisticated legal strategies to protect intellectual assets.
Recently, Buchalter has been active in enhancing its service offerings across various practice areas, including the medical technology sphere, which requires a robust approach to intellectual property given the fast pace of innovation. The leadership change is expected to further establish Buchalter as a significant player in providing specialized legal services to the medical tech industry. For Buchalter, this move is part of a broader initiative to refine its service model and respond dynamically to industry changes, as detailed in analyses by other legal publications such as Above the Law and its evaluation of law firm expansions.
As healthcare innovation continues to advance, the integration of seasoned IP professionals into leadership positions within legal firms highlights the increasing importance of protecting technological advancements. Buchalter’s strategic hiring decision underscores the critical role of intellectual property law in supporting the development and commercialization of medical technologies.